Propofol Batch Discontinued Following Drug Safety Concerns in Rohtak

The Directorate of Medical Education issued directions ordering the immediate discontinuation of a specific batch of propofol, an anesthetic drug, at Pandit Bhagwat Dayal Sharma University of Health Sciences in Rohtak. This action followed suspicions regarding nearly half a dozen deaths that occurred after elective surgeries in July and August. The District Drug Controller seized the drug batch for laboratory testing.

The withdrawal of the specific drug batch and subsequent testing raise questions about the drug's quality, even though no direct link between the drug and the reported fatalities has been established. This regulatory action impacts the local medical supply chain and hospital operations in Rohtak.